Chase Science Co AAQS
The The AAQS of Chase Science Co (300941.SZ) as of Oct 22, 2026 is 2. In the previous year, The AAQS was 2.00 — a change of 0.00% (lower).
Get this data via API
Financial Data API
AAQS
2
YoY
0.00%
Last updated:
Chase Science Co has a current AAQS of 2.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Chase Science Co in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Chase Science Co in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
The Chase Science Co AAQS history
3 Years
10 Years
25 Years
Max
AAQS
Date
AAQS
Jan 1, 2018
2.00 CNY
Jan 1, 2019
2.00 CNY
Jan 1, 2020
2.00 CNY
Jan 1, 2021
2.00 CNY
Jan 1, 2022
2.00 CNY
Jan 1, 2023
2.00 CNY
Jan 1, 2024
2.00 CNY
Jan 1, 2025
2.00 CNY
| YEAR | AAQS | YoY |
|---|---|---|
| 2 | 0.00% | |
| 2 | 0.00% | |
| 2 | 0.00% | |
| 2 | 0.00% | |
| 2 | 0.00% | |
| 2 | 0.00% | |
| 2 | 0.00% | |
| 2 | 0.00% | |
| 2 | 0.00% | |
| 2 | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Chase Science Co Stock analysis
What does Chase Science Co do? Chase Science Co., Ltd. generates revenue through the development, sales, and services of electronic payment information technology systems. The company offers merchant-side payment solutions, including software and hardware products and services for merchants, and bank-side products such as network control products and card manufacturing equipment, alongside related services. Its primary customers are merchants and banks, with revenue streams derived from software development, technical services, project maintenance, and product upgrades. The firm's product portfolio is segmented into merchant-focused and bank-focused offerings, each delivering tailored solutions for electronic payment processing and infrastructure management.
Chase Science Co., Ltd. provides comprehensive services including project maintenance and product upgrade services, which contribute to recurring revenue from its merchant and bank clients. The company's business model emphasizes long-term client relationships through ongoing technical support and product enhancements. Revenue is generated through both one-time sales of hardware and software and continuous service contracts, ensuring steady income from established customer segments.
The firm's merchant-side payment solutions are designed to support merchants in electronic payment processing, while bank-side products focus on network control and card manufacturing equipment, serving financial institutions' operational needs. By offering integrated services across both segments, Chase Science Co., Ltd. secures a diversified revenue base, with key income sources including software development, technical services, and maintenance contracts for its core product lines. Chase Science Co is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Chase Science Co stock
The AAQS of Chase Science Co is 2 in 2025.
On Eulerpool you can find the complete historical development of The AAQS Chase Science Co since 2006 – with annual values, charts, and detailed analysis.
The AAQS is a key figure developed by AlleAktien.
The AAQS is a key figure developed by AlleAktien.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Quality — Chase Science Co
All Key Metrics — Chase Science Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth